NFKB1 and breast cancer: NFkB is constitutively activated in ER−negative and TN breast tumors, mediates adaptive resistance to ionizing radiation and chemotherapy, and is required for epithelial–mesenchymal transition (EMT) associated with metastatic progression of BC.